PAPER Sydow A, Van der Jeugd A, Zheng F, Ahmed T, Balschun D, Petrova O, Drexler D, Zhou L, Rune G, Mandelkow E, D'Hooge R, Alzheimer C, Mandelkow EM
SEARCH RESULTS
329939 RESULTS
PAPER Caselli RJ, Dueck AC, Locke DE, Sabbagh MN, Ahern GL, Rapcsak SZ, Baxter LC, Yaari R, Woodruff BK, Hoffman-Snyder C, Rademakers R, Findley S, Reiman EM
Cerebrovascular risk factors and preclinical memory decline in healthy APOE ε4 homozygotes.
Neurology. 2011 Mar 22;76(12):1078-84. PubMed: 21325652PAPER Koivunen J, Scheinin N, Virta JR, Aalto S, Vahlberg T, Någren K, Helin S, Parkkola R, Viitanen M, Rinne JO
Amyloid PET imaging in patients with mild cognitive impairment: a 2-year follow-up study.
Neurology. 2011 Mar 22;76(12):1085-90. PubMed: 21325653PAPER Wilson AC, Dugger BN, Dickson DW, Wang DS
TDP-43 in aging and Alzheimer's disease- a review.
Int J Clin Exp Pathol. 2011;4(2):147-55. PubMed: 21326809PAPER Pardridge WM
Biologic TNFα-inhibitors that cross the human blood-brain barrier.
Bioeng Bugs. 2010 Jul-Aug;1(4):231-4. PubMed: 21327054PAPER Kume K, Hanyu H, Sato T, Hirao K, Shimizu S, Kanetaka H, Sakurai H, Iwamoto T
Vascular risk factors are associated with faster decline of Alzheimer disease: a longitudinal SPECT study.
J Neurol. 2011 Jul;258(7):1295-303. PubMed: 21327852Anna Chiarini
University of VeronaVerona, Italy
Desai Alpeshkumar
Patan, India
PAPER Chu C, Selwyn PA
Complications of HIV infection: a systems-based approach.
Am Fam Physician. 2011 Feb 15;83(4):395-406. PubMed: 21322514PAPER Bach A, Eildal JN, Stuhr-Hansen N, Deeskamp R, Gottschalk M, Pedersen SW, Kristensen AS, Strømgaard K
Cell-permeable and plasma-stable peptidomimetic inhibitors of the postsynaptic density-95/N-methyl-D-aspartate receptor interaction.
J Med Chem. 2011 Mar 10;54(5):1333-46. PubMed: 21322614PAPER Thapa A, Woo ER, Chi EY, Sharoar MG, Jin HG, Shin SY, Park IS
Biflavonoids are superior to monoflavonoids in inhibiting amyloid-β toxicity and fibrillogenesis via accumulation of nontoxic oligomer-like structures.
Biochemistry. 2011 Apr 5;50(13):2445-55. PubMed: 21322641PAPER Kolykhalov IV, Rassadina GA, Gavrilova SI, Gerasimov NP
[Cholinergic therapy of Alzheimer's disease and its effect on health and quality of life of caregivers to the patients].
Zh Nevrol Psikhiatr Im S S Korsakova. 2010;110(5 Pt 1):33-8. PubMed: 21322823PAPER Shah S, Federoff HJ
Therapeutic potential of vaccines for Alzheimer's disease.
Immunotherapy. 2011 Feb;3(2):287-98. PubMed: 21322764PAPER Dekosky ST, Carrillo MC, Phelps C, Knopman D, Petersen RC, Frank R, Schenk D, Masterman D, Siemers ER, Cedarbaum JM, Gold M, Miller DS, Morimoto BH, Khachaturian AS, Mohs RC
Revision of the criteria for Alzheimer’s disease: A symposium.
Alzheimers Dement. 2011 Jan;7(1):e1-12. PubMed: 21322828PAPER Garai K, Baban B, Frieden C
Dissociation of apolipoprotein E oligomers to monomer is required for high-affinity binding to phospholipid vesicles.
Biochemistry. 2011 Apr 5;50(13):2550-8. PubMed: 21322570Current Filters
No filters selected